**Miami Valley Hospital Inpatient Discharge Summary**

---

**[B-NAME]Margaret Chen[O], MRN# [B-ID]1557429[O], is a [B-AGE]72 y.o.[O] [B-DATE]female, admitted to the Geriatric Medicine service for management of her chronic heart failure and type 2 diabetes.**

Admission Date: [B-DATE]9/7/2023[O]  
Discharge Date: [B-DATE]9/21/2023[O]  
Attending Provider: Dr. [B-NAME]Emily Jameson[O]  
Treatment Team:  
- Primary Nurse: [B-NAME]Patricia Neal[O], RN  
- Consulting Cardiologist: Dr. [B-NAME]Ian McKellen[O]  
- Endocrinologist: Dr. [B-NAME]Sarah Gold[O]  

**Hospital Problems Noted - Resolved**  
POA Active Problems  
- Decompensated heart failure [B-DATE]9/8/2023[O] - Present Yes  
- Uncontrolled diabetes mellitus [B-DATE]9/10/2023[O] - Present Yes  
- Hypertension [B-DATE]9/7/2023[O] - Present Yes  

**Other Problems**  
- Minor urinary tract infection treated with antibiotics

**Hospital Course: Brief Overview**  
Ms. [B-NAME]Chen[O] was admitted with signs of fluid overload and shortness of breath. Initial evaluations confirmed exacerbation of her heart failure, compounded by poorly controlled blood glucose levels. The cardiology team optimized her diuretic therapy, resulting in improved symptoms. Endocrinology adjusted her diabetic regimen, aiming for tighter glucose control without risking hypoglycemia, given her age and comorbidities.

Significant interventions included:  
- Increase in furosemide dose from 40 mg to 80 mg daily.  
- Adjustment of insulin regimen to better correlate with mealtime glucose monitoring.  
- Introduction of a low-dose ACE inhibitor for BP control and cardiovascular protection.

**Discharge Condition:**  
- Condition stabilized with an improvement in cardiac function and glucose control.  
- Follow up with cardiology and endocrinology advised within the next two weeks.

Discharge Medication:  
1. Furosemide 80 mg tablet, daily  
2. Metformin 500 mg, twice daily  
3. Lisinopril 5 mg, once daily  

**Follow-Up Orders:**  
- Outpatient follow-up with Dr. [B-NAME]Ian McKellen[O] at [B-ORGANIZATION]Heart Care Associates[O] on [B-DATE]10/1/2023[O].  
- Diabetes management review with Dr. [B-NAME]Sarah Gold[O] at [B-ORGANIZATION]Endocrine Specialists, Inc.[O] on [B-DATE]10/3/2023[O].  

**Safety Plan and Instructions:**  
- Ms. [B-NAME]Chen[O] and her daughter, [B-NAME]Susan Lei[O], have been instructed on recognizing signs of fluid retention and hypoglycemia.  
- They have also been advised on the proper administration of new medications.

**Emergency Contact:**  
- Daughter, [B-NAME]Susan Lei[O], Phone: [B-PHONE]305-555-0198[O]

**Discharge Status:**  
The patient was discharged in a stable condition, ambulating with minimal assistance, and understanding her discharge instructions fully. 

**Last Recorded Vital Signs:**  
BP 132/82 | Pulse 78 | Resp 16 | SpO2 97% | Wt 68 kg (150 lb)

---

**Signed:**  
[B-NAME]Emily Jameson[O], MD  
[B-DATE]9/21/2023[O], 11:30 AM
